Stay updated on Nivolumab and SRS in Recurrent Meningioma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has updated its date references, removing older dates and adding new ones for February 2025.
    Difference
    0.2%
    Check dated 2025-03-04T04:01:28.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The webpage has updated its clinical trial data sharing policies and removed outdated information regarding objective response rates and survival metrics. Additionally, new dates for data sharing plans have been introduced.
    Difference
    2%
    Check dated 2025-02-24T23:02:02.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.7%
    Check dated 2025-02-10T16:35:20.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.0%
    Check dated 2025-02-03T11:41:43.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.0%
    Check dated 2025-01-20T03:27:12.000Z thumbnail image
  9. Check
    74 days ago
    Change Detected
    Summary
    The website has updated its contact information for several site public contacts and has revised the version from v2.13.3 to v2.14.0, while removing the previous type of intervention and associated principal investigator details.
    Difference
    9%
    Check dated 2025-01-12T23:19:53.000Z thumbnail image

Stay in the know with updates to Nivolumab and SRS in Recurrent Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.